Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
14 Febbraio 2024 - 11:42PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
13G/A
(Amendment
No. 3)
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
VIVOS
THERAPEUTICS, INC.
(Name
of Issuer)
Common
stock, par value $0.0001 per share
(Title
of Class of Securities)
92859E207
(CUSIP
Number)
December
31, 2023
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
☐ |
Rule
13d-1(b) |
|
☐ |
Rule
13d-1(c) |
|
☒ |
Rule
13d-1(d) |
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
page.
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP
92859E207
1. |
Name
of Reporting Persons
Coronado V Partners, LLC |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a)
☐ (b) ☐ |
3. |
SEC
Use Only
|
4. |
Citizenship
or Place of Organization
Wyoming |
Number
of
Shares
Beneficially
Owned
By
Each
Reporting
Person
With: |
5. |
Sole
Voting Power
69,600(1) |
6. |
Shared
Voting Power
0 |
7. |
Sole
Dispositive Power
69,600(1) |
8. |
Shared
Dispositive Power
0 |
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
69,600(1) |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares
|
11. |
Percent
of Class Represented by Amount in Row (9)
3.2%(1) |
12. |
Type
of Reporting Person (See Instructions)
OO |
(1)
See Item 4.
CUSIP
92859E207
1. |
Names
of Reporting Persons
R. Kirk Huntsman |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a)
☐ (b) ☐ |
3. |
SEC
Use Only
|
4. |
Citizenship
or Place of Organization
United
States |
Number
of
Shares
Beneficially
Owned
By
Each
Reporting
Person
With: |
5. |
Sole
Voting Power
94,794(1) |
6. |
Shared
Voting Power
0 |
7. |
Sole
Dispositive Power
94,794(1) |
8. |
Shared
Dispositive Power
0 |
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
94,794(1) |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares
|
11. |
Percent
of Class Represented by Amount in Row (9)
4.3%(1) |
12. |
Type
of Reporting Person (See Instructions)
IN |
(1)
See Item 4.
Item
1(a). |
Name
of Issuer |
Vivos
Therapeutics, Inc. (the “Issuer”)
Item
1(b). |
Address
of the Issuer’s Principal Executive Offices |
7921
Southpark Plaza, Suite 210
Littleton,
Colorado 80120
Item
2(a). |
Names
of Persons Filing |
Coronado
V Partners, LLC and R. Kirk Huntsman (collectively, the “Reporting Persons”)
Item
2(b). |
Address
of the Principal Business Office, or if none, Residence: |
7921
Southpark Plaza, Suite 210
Littleton,
Colorado 80120
Coronado
V Partners, LLC is a Wyoming limited liability company. R. Kirk Huntsman is a citizen of the United States of America.
Item
2(d). |
Title
of Class of Securities |
Common
stock, $0.0001 par value per share.
92859E207
Item
3. |
If
this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
☐ |
(a) Broker or Dealer registered
under Section 15 of the Exchange Act. |
|
|
☐ |
(b) Bank as defined in
Section 3(a)(b) or the Exchange Act. |
|
|
☐ |
(c) Insurance company as
defined in Section 3(a)(19) of the Exchange Act. |
|
|
☐ |
(d) Investment company
registered under Section 8 of the Investment Company Act. |
|
|
☐ |
(e) An Investment adviser
in accordance with Rule 13d-1 (b)(1)(ii)(e). |
|
|
☐ |
(f) An employee benefit
plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f). |
|
|
☐ |
(g) A Parent Holding Company
or control person in accordance with Rule 13d 1(b)(1)(ii)(g). |
|
|
☐ |
(h) A Savings Association
as defined in Section 3(b) of the Federal Deposit Insurance Act. |
|
|
☐ |
(i) A Church Plan that
is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act. |
|
|
☐ |
(j) Group, in accordance
with Rule 13d-1 (b)(1)(ii)(j). |
|
|
|
Not applicable. |
The
responses to Items 5-10 of the cover pages of this Schedule 13G are incorporated herein by reference.
As
of February 14, 2024, Coronado V Partners, LLC and R. Kirk Huntsman may
be deemed to beneficially own 69,600 shares and 94,794 shares, respectively, of the Issuer’s common stock, representing 3.2% and
4.3%, respectively, of the total shares of common stock issued and outstanding.
The
percentages of the shares of common stock held by the Reporting Persons
are based on 2,207,651 shares of common stock issued and outstanding as of February 13, 2024. All common stock share amounts and percentage
interests in this Schedule 13G (Amendment No. 3) give effect to the 1-for-25 reverse stock split of the Issuer’s common stock which
became effective on October 25, 2023.
As
of February 14, 2024, Coronado V Partners, LLC is the record holder of
69,600 shares of common stock. R. Kirk Huntsman is the record holder of 94,794 shares of common stock. R. Kirk Huntsman is the president
of Coronado V Partners, LLC and has voting and investment discretion with respect to the common stock held of record by Coronado V Partners,
LLC. As such, Mr. Huntsman may be deemed to have beneficial ownership of the securities held of record by Coronado V Partners, LLC. The
93,794 shares held of record by Mr. Huntsman includes 21,733 shares of common stock issuable upon exercise of options held by Mr. Huntsman,
all of which are presently exercisable.
Item 5. |
Ownership of Five Percent or Less of a Class |
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following ☒
Item 6. |
Ownership of More than Five Percent on Behalf of
Another Person |
Not
applicable.
Item 7. |
Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
Not
applicable.
Item 8. |
Identification and Classification of Members of
the Group |
Not
applicable.
Item 9. |
Notice of Dissolution of Group |
Not
applicable.
Not
applicable.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Date:
February 14, 2024
|
Coronado V Partners, LLC |
|
|
|
|
By: |
/s/ R.
Kirk Huntsman |
|
Name: |
R. Kirk Huntsman |
|
Title: |
President |
|
/s/ R.
Kirk Huntsman |
|
R. Kirk Huntsman |
Grafico Azioni Vivos Therapeutics (NASDAQ:VVOS)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Vivos Therapeutics (NASDAQ:VVOS)
Storico
Da Gen 2024 a Gen 2025